Perceived difficulty and self-efficacy in the factor structure of perceived behavioral control to seek drug information from physicians and pharmacists

Research in Social and Administrative Pharmacy

Volumn 3, Issue 2, 2007, Pages 145-159

  Liu, Yifei ^a   Doucette, William R ^a   Farris, Karen B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Controllability; Drug information; Perceived behavioral control; Perceived difficulty; Self efficacy; Theory of planned behavior

Indexed keywords

DRUG;

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN RELATION; MALE; MIDDLE AGED; OSTEOARTHRITIS; PHARMACIST; QUESTIONNAIRE; SELF CONCEPT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHYSICIAN-PATIENT RELATIONS; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; SELF EFFICACY;

EID: 34249869275     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.07.002     Document Type: Article

References (44)

1. United States General Accounting Office. FDA oversight of direct-to-consumer advertising has limitations. Report to congressional requesters. Report no GAO-03-177. Oct 2000.
2. Yuan Y., and Duckwitz N. Doctors and DTC. Available at: (2002). www.imshealth.com Accessed 19.02.03
3. Melillo W. FDA cites most DTC drug spots. Adweek 40 (1999) 4
4. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep 68 (2003) 33-37
5. Moncavage M. US FDA, Division of Drug Marketing, Advertising and Communications. DTC prescription drug promotion update from FDA. Presented at DTC National 2003. Boston, MA. March, 2003. Available at: www.fda.gov/cder/ddmac/presentations.htm. Accessed 20.04.03.
6. FDA. Warning Letter to Merck & Co Inc. NDA 21-042 MACMIS ID # 9456 Vioxx (rofecoxib) tablets. Rockville, MD: FDA, 2001.
7. FDA. Letter to G.D. Searle & Co. re NDA 20-998 Celebrex (celecoxib) capsules, NDA 19-908 Ambien (zolpidem tartrate) tablets MACMIS ID #8518. Department of Health & Human Services, 2000.
8. FDA. Letter to G.D. Searle & Co. re NDA 20-998 Celebrex (celecoxib) capsules MACMIS ID #9514. Department of Health & Human Services, 2000.
9. ® (2004), United Press International, New York, NY
10. ®. CNN news. New York, NY. 2004. Available at: money.cnn.com/2004/12/20/news/celebrex/index.htm. Accessed 21.12.04.
11. Young D. FDA examines direct-to-consumer advertising data. Am J Health Syst Pharm 60 (2003) 2420, 2422, 2424 passim
12. Aikin JK. US FDA, Division of Drug Marketing, Advertising and Communications. Direct-to-consumer advertising of prescription drugs: patient survey results. Presented at Healthcare Marketing Communications Council. Sep, 2002. Available at: www.fda.gov/cder/ddmac/presentations.htm. Accessed 20.01.03.
13. Ricker D.C. The health belief model and consumer information searches: toward an integrated model. Health Mark Q 13 (1996) 13-26
14. Liu Y., Doucette W.R., Farris K.B., and Nayakankuppam D. Drug information seeking intention and behavior after exposure to direct-to-consumer advertisement (DTCA) of prescription drugs. Res Soc Adm Pharm 1 (2005) 251-269
15. Ajzen I. Attitudes, Personality, and Behavior (1988), Dorsey Press, Chicago, IL
16. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 50 (1991) 179-211
17. Ajzen I., and Madden T.J. Prediction of goal-directed behavior: attitudes, intentions, and perceived behavioral control. J Exp Soc Psychol 22 (1986) 453-474
18. Ajzen I. Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. J Appl Soc Psychol 32 (2002) 1-20
19. Trafimow D., Sheeran P., Conner M., and Finlay K.A. Evidence that perceived behavioral control is a multidimensional construct: perceived control and perceived difficulty. Br J Soc Psychol 41 (2002) 101-121
20. Bandura A. Self-efficacy mechanism in human agency. Am Psychol 37 (1982) 122-147
21. Montano D.E., and Kasprzyk D. Chapter 4, The theory of reasoned action and the theory of planned behavior. In: Glanz K., Rimer B.K., and Lewis F.M. (Eds). Health Behavior and Health Education: Theory, Research and Practice. 3rd ed. (2002), Jossey-Bass Publishers, San Francisco, CA 69-76
22. Manstead A.S.R., and van Eekelen S.A.M. Distinguishing between perceived behavioral control and self-efficacy in the domain of academic intentions and behaviors. J Appl Soc Psychol 28 (1998) 1375-1392
23. Armitage C.J., and Conner M. The theory of planned behaviour: assessment of predictive validity and "perceived control". Br J Soc Psychol 38 (1999) 35-54
24. Armitage C.J., and Conner M. Distinguishing perceptions of control from self-efficacy: predicting consumption of a low-fat diet using the theory of planned behavior. J Appl Soc Psychol 29 (1999) 72-90
25. Armitage C.J., and Conner M. Social cognitive determinants of blood donation. J Appl Soc Psychol 31 (2001) 1431-1457
26. Terry D.J., and O'Leary J.E. The theory of planned behaviour: the effects of perceived behavioural control and self-efficacy. Br J Soc Psychol 34 (1995) 199-220
27. Sparks P., Guthrie C.A., and Shepherd R. The dimensional structure of the perceived behavioral control construct. J Appl Soc Psychol 27 (1997) 418-438
28. Povey R., Conner M., Sparks P., James R., and Shepherd R. Application of the theory of planned behaviour to two dietary behaviours: roles of perceived control and self-efficacy. Br J Health Psychol 5 (2000) 121-139
29. Rhodes R.E., and Courneya K.S. Self-efficacy, controllability and intention in the theory of planned behavior: measurement redundancy or causal independence?. Psychol Health 18 (2003) 79-91
30. Rhodes R.E., and Courneya K.S. Differentiating motivation and control in the theory of planned behavior. Psychol Health Med 9 (2004) 205-215
31. Felson D.T., Lawrence R.C., Diepe P.A., et al. Osteoarthritis: new insights. Part 1: The disease and its risk factors. Ann Intern Med 133 (2000) 635-646
32. Weissman J.S., Blumenthal D., Silk A.J., Zapert K., Newman M., and Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Aff (2003) Suppl:W3-82-95
33. Odedina F.T., Helper C.D., Segal R., and Miller D. The pharmacist's implementation of pharmaceutical care (PIPC) model. Pharm Res 14 (1997) 135-144
34. Farris K.B., and Schopflocher D.P. Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med 49 (1999) 55-66
35. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84 (1977) 191-215
36. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory (1986), Prentice-Hall, Englewood Cliffs, NJ
37. Levy P.S., and Lemeshow S. How large a sample do we need? Chapter 3. Simple random sampling. In: Levy P.S., and Lemeshow S. (Eds). Sampling of Population: Methods and Application. 3rd ed. (1999), John Wiley & Sons, New York, NY 70-75
38. Dillman D.A. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. (1999), John Wiley Company, New York, NY
39. Fabrigar L.R., Wegener D.T., MacCallum R.C., and Strahan E.J. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 4 (1999) 272-299
40. Costello A.B., and Osborne J.W. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval 10 (2005) 1-9
41. Tabachnick B.G., and Fidell L.S. Using Multivariate Statistics (2001), Allyn and Bacon, Boston, MA
42. Maddux J.E. Chapter 1, Self-efficacy theory: an introduction. In: Maddux J.E. (Ed). Self-efficacy, Adaptation, and Adjustment: Theory, Research, and Application (1995), Plenum Press, New York, NY 3-27
43. Roter D.L. Patient question asking in physician-patient interaction. Health Psychol 3 (1984) 395-409
44. Schommer J.C., and Wiederholt J.B. Pharmacists' perceptions of patients' needs for counseling. Am J Hosp Pharm 51 (1994) 478-485